BTIG Reiterates Buy on Sensei Biotherapeutics, Maintains $55 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.0%

Neg 0% Neu 85% Pos 0%

BTIG analyst Jeet Mukherjee reiterates Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy and maintains $55 price target.

Comments

No comments yet. Be the first!